Dimed S.A. Distribuidora de Medicamentos reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net income was BRL 15.65 million compared to BRL 15.55 million a year ago. For the nine months, net income was BRL 56.23 million compared to BRL 33.47 million a year ago. Basic earnings per share from continuing operations was BRL 0.38. Diluted earnings per share from continuing operations was BRL 0.37.